132 related articles for article (PubMed ID: 2501541)
1. [Coronary thrombolysis by t-PA and pro-UK].
Kanmatsuse K; Suzuki T; Kajiwara N
Nihon Rinsho; 1989 Apr; 47(4):910-6. PubMed ID: 2501541
[No Abstract] [Full Text] [Related]
2. Tissue-type plasminogen activator for acute coronary thrombosis.
Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
[No Abstract] [Full Text] [Related]
3. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
4. Clot-selective thrombolysis: the impact of tissue-type plasminogen activator (t-PA) in thromboembolic diseases.
Bounameaux H
Vasa; 1986; 15(2):115-8. PubMed ID: 3088866
[No Abstract] [Full Text] [Related]
5. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
Van de Werf F; Jang IK; Collen D
J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
[TBL] [Abstract][Full Text] [Related]
6. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
Collen D
Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
[No Abstract] [Full Text] [Related]
8. The thrombolytic effects of native tissue-type plasminogen activator (AK-124) on experimental canine coronary thrombosis.
Tomaru T; Uchida Y; Sonoki H; Tsukamoto M; Sugimoto T
Angiology; 1989 May; 40(5):429-35. PubMed ID: 2495745
[TBL] [Abstract][Full Text] [Related]
9. Clot-selective coronary thrombolysis with pro-urokinase.
Loscalzo J; Wharton TP; Kirshenbaum JM; Levine HJ; Flaherty JT; Topol EJ; Ramaswamy K; Kosowsky BD; Salem DN; Ganz P
Circulation; 1989 Apr; 79(4):776-82. PubMed ID: 2494004
[TBL] [Abstract][Full Text] [Related]
10. [New methods of thrombolysis].
Vinazzer H
Wien Med Wochenschr; 1987 Jun; 137(10-11):221-4. PubMed ID: 2955574
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators and their potential in therapy.
Hollander IJ
Crit Rev Biotechnol; 1987; 6(3):253-71. PubMed ID: 3146436
[TBL] [Abstract][Full Text] [Related]
12. Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.
Susawa T; Yui Y; Hattori R; Takahashi M; Aoyama T; Takatsu Y; Sakaguchi K; Yui N; Kawai C
Jpn Circ J; 1987 Apr; 51(4):431-5. PubMed ID: 2441082
[TBL] [Abstract][Full Text] [Related]
13. Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model.
Fincke U; Schneider J; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1988 Jan; 38(1):138-42. PubMed ID: 3365272
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
Susawa T; Yui Y; Hattori R; Takatsu Y; Yui N; Takahashi M; Aoyama T; Murohara Y; Shirotani M; Kawai C
Jpn Circ J; 1988 Jan; 52(1):72-8. PubMed ID: 3129601
[TBL] [Abstract][Full Text] [Related]
15. Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator.
Gurewich V
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):16B-21B. PubMed ID: 3117859
[TBL] [Abstract][Full Text] [Related]
16. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
Czyrski J
Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
[TBL] [Abstract][Full Text] [Related]
17. A novel modified tissue-type plasminogen activator (t-PA), E6010, reduces reperfusion arrhythmias induced after coronary thrombolysis--comparison of native t-PA and urokinase.
Saito M; Suzuki S; Yui Y; Kawai C
Jpn Circ J; 1995 Aug; 59(8):556-64. PubMed ID: 7474300
[TBL] [Abstract][Full Text] [Related]
18. [Acute myocardial infarction and coronary thrombolysis].
Kanmatsuse K
Rinsho Ketsueki; 1996 Sep; 37(9):813-6. PubMed ID: 8914468
[No Abstract] [Full Text] [Related]
19. Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator.
Yamada Y; Furui H; Furumichi T; Yamauchi K; Yokota M; Saito H
Am Heart J; 1991 Jun; 121(6 Pt 1):1618-27. PubMed ID: 1903579
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator for coronary thrombosis.
DiPalma JR
Am Fam Physician; 1988 Mar; 37(3):291-5. PubMed ID: 3126630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
